Skip to Main Content

Author Details

Arvind H Patel
MRC-University of Glasgow Centre for Virus Research
1987
140
55
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36840596Evaluation of an Engineered Zika Virus-Like Particle Vaccine Candidate in a Mosquito-Mouse Transmission Model.mSphere2023
37610841Multiplexed Biosensing of Proteins and Virions with Disposable Plasmonic Assays.ACS Sens2023
37446546Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.Molecules2023
36719195Effect of Glycan Shift on Antibodies against Hepatitis C Virus E2 412-425 Epitope Elicited by Chimeric sHBsAg-Based Virus-Like Particles.Microbiol Spectr2023
34655573An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.Gastroenterology2022
35763545A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo.PLoS Pathog2022
35529317Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model.PNAS Nexus2022
35891372The Neutralizing Antibody Responses of Individuals That Spontaneously Resolve Hepatitis C Virus Infection.Viruses2022
36350154The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.J Virol2022
36016278A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of <i>ARHGEF3/XPLN</i> Inhibits Replication of Hepatitis C Virus and Other Flavivirids.Viruses2022
35093235Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.Cell Rep2022
33420102Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design.NPJ Vaccines2021
33672697Design and Synthesis of HCV-E2 Glycoprotein Epitope Mimics in Molecular Construction of Potential Synthetic Vaccines.Viruses2021
34855916Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.PLoS Pathog2021
34680227HCV Activates Somatic L1 Retrotransposition-A Potential Hepatocarcinogenesis Pathway.Cancers (Basel)2021
34534263In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.PLoS Pathog2021
33397804Diversification of mammalian deltaviruses by host shifting.Proc Natl Acad Sci U S A2021
32560145Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.Vaccines (Basel)2020
31984607Improving the aqueous solubility of HCV-E2 glycoprotein epitope mimics by cyclization using POLAR hinges.J Pept Sci2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33028720Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.J Virol2020
32980446Generation of a reporter yellow fever virus for high throughput antiviral assays.Antiviral Res2020
30661824Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV).Bioorg Med Chem Lett2019
29128754Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.Virology2018
29934593Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.Nat Commun2018
30013555Predicting the Effectiveness of Hepatitis C Virus Neutralizing Antibodies by Bioinformatic Analysis of Conserved Epitope Residues Using Public Sequence Data.Front Immunol2018
29387631Dengue Virus Capsid Interacts with DDX3X-A Potential Mechanism for Suppression of Antiviral Functions in Dengue Infection.Front Cell Infect Microbiol2018
29382188Immobilization by Surface Conjugation of Cyclic Peptides for Effective Mimicry of the HCV-Envelope E2 Protein as a Strategy toward Synthetic Vaccines.Bioconjug Chem2018
29631174Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.Virology2018
2788581117,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle.Liver Int2017
29074219A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.Antiviral Res2017
28916719KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.Sci Immunol2017
28512091Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.mBio2017
28558001Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.PLoS One2017
28761359Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer.Onco Targets Ther2017
26819303Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422.J Virol2016
26404951Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.Gastroenterology2016
27706161Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.PLoS Negl Trop Dis2016
27558078Corrigendum: Exploration of acetanilide derivatives of 1-(Ï¿-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication.Sci Rep2016
27406141Exploration of acetanilide derivatives of 1-(Ï¿-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication.Sci Rep2016
27405885Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection.J Viral Hepat2016
27279607Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.J Virol2016
27092143Tracking TCRβ Sequence Clonotype Expansions during Antiviral Therapy Using High-Throughput Sequencing of the Hypervariable Region.Front Immunol2016
26912610Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection.J Virol2016
26710081Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.Hepatology2016
25200131Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.J Viral Hepat2015
26428870Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents.Bioorg Med Chem Lett2015
26315040In memoriam--Richard M. Elliott (1954-2015).J Gen Virol2015
25800823Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection.Liver Int2015
24830295Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.PLoS Pathog2014
  • 1 - 50 of 140

Recommended Authors

Nawneet Mishra
Washington University School of Medicine in St. Louis
Career Start Year 2015
Number of shared co-authors 3
Ragunath Singaravelu
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 0
Thibaut Vausselin
CNRS, INSERM, Institut Pasteur de Lille, Center for Infection and Immunity of Lille
Career Start Year 2010
Number of shared co-authors 4
Thomas J Gardner
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 4
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 4
Danyang Gong
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 3
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 5
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 1
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 3
Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
Career Start Year 2000
Number of shared co-authors 4
Armin Baiker
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
Career Start Year 1999
Number of shared co-authors 1
Lily Tong
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 3
Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 1997
Number of shared co-authors 3
Becket Feierbach
Gilead Sciences Inc.
Career Start Year 1997
Number of shared co-authors 0
Jan E Carette
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 15
J??rgen Haas
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 3
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 8
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
Keith Meyer
Saint Louis University
Career Start Year 1994
Number of shared co-authors 0
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 5
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 7
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 5
Ren Sun
University of California los angeles
Career Start Year 1992
Number of shared co-authors 6
Leslie Lobel
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
Albrecht von Brunn
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
Career Start Year 1983
Number of shared co-authors 1
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 7
David I Stuart
University of Oxford
Career Start Year 1976
Number of shared co-authors 2
Aleem Siddiqui
University of California
Career Start Year 1974
Number of shared co-authors 1
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 2
Eric Hunter
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Vanessa M Cowton
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Co-authored papers 11
Giuditta De Lorenzo
MRC-University of Glasgow Centre for Virus Research
Co-authored papers 9
Massimo Palmarini
MRC-University of Glasgow Centre for Virus Research
Co-authored papers 6
Charles M Rice
Rockefeller University
Co-authored papers 4
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 3
Wilhelm Furnon
MRC-University of Glasgow Centre for Virus Research
Co-authored papers 3
Dan H Barouch
Co-authored papers 2
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Hannes Braberg
University of California San Francisco
Co-authored papers 1
Daniel J Saltzberg
University of California san francisco
Co-authored papers 1
Rachel Toth
University of Dundee
Co-authored papers 1
Danish Memon
European Bioinformatics Institute
Co-authored papers 1
Mohd Anisul Karim
Wellcome Trust Sanger Institute
Co-authored papers 1
Eric Tse
School of Clinical Medicine, University of Hong Kong
Co-authored papers 1
Matthew Elliott
College of Life Sciences, University of Dundee
Co-authored papers 1
Mansun Law
The Scripps Research Institute
Co-authored papers 1
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Gregory E Merz
University of California san francisco
Co-authored papers 1
Zun Zar Chi Naing
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Nadia Herrera
University of California san francisco
Co-authored papers 1
Ming Sun
Columbia University
Co-authored papers 1
Loan Doan
University of California san francisco
Co-authored papers 1
Maliheh Safari
University of California san francisco
Co-authored papers 1
Anthony J Hodder
University of Sheffield
Co-authored papers 1
Justin T Biel
University of California san francisco
Co-authored papers 1
Ishan Deshpande
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Fengbo Zhou
Washington University School of Medicine
Co-authored papers 1
David E Gordon
Emory University
Co-authored papers 1
Release 1.2